$GERN Headlines Baker Hughes, Halliburton gain
Post# of 89342
Posted On: 01/14/2015 10:42:59 AM
$GERN Headlines
Baker Hughes, Halliburton gain on potential merger; Fossil in red 10:07 a.m. Nov. 14, 2014 - Sue Chang
Looming $40 crude and how to vape your way to profits 5:47 a.m. Nov. 14, 2014 - Shawn Langlois
Baker Hughes shares rise on possible buyout 6:02 p.m. Nov. 13, 2014 - Wallace Witkowski
Herbalife shares drop after hours as earnings disappoint 6:58 p.m. Nov. 3, 2014 - Wallace Witkowski
Geron's stock soars after FDA lifts hold on new drug application 7:48 a.m. Nov. 3, 2014 - Tomi Kilgore
Geron's stock jumps 35% premarket after FDA lifts hold on new drug application 7:35 a.m. Nov. 3, 2014 - Tomi Kilgore
FDA places hold on Geren's Imetelstat application 7:25 a.m. March 12, 2014 - MarketWatch.com
Charting the latest market whipsaw 10:59 a.m. Nov. 11, 2013 - Michael Ashbaugh
Oracle active, Geron shares fall after hours 6:06 p.m. Dec. 3, 2012 - Carla Mozee
Geron to discontinue brain-cancer drug development 4:38 p.m. Dec. 3, 2012 - MarketWatch.com
BioTime offers equity stake for Geron assets 8:47 a.m. Oct. 18, 2012 - MarketWatch.com
Monday’s biggest gaining and declining stocks 1:42 p.m. Sept. 10, 2012 - MarketWatch
Geron ends breast cancer study of Imetelstat 7:06 a.m. Sept. 10, 2012 - MarketWatch.com
Stocks to Watch Friday: Splunk, Zumiez, Pandora 3:59 p.m. Aug. 30, 2012 - David B. Wilkerson
Thursday’s biggest gaining and declining stocks 3:31 p.m. Aug. 30, 2012 - MarketWatch
Geron climbs 11% on analyst rating 9:56 a.m. Aug. 30, 2012 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 5:37 p.m. Nov. 15, 2011 - Kate Gibson
Financial uncertainty nixed Geron stem cell work 2:09 p.m. Nov. 15, 2011 - MarketWatch.com
Stocks to watch Friday: Global Crossing, Clarcor 5:42 a.m. Sept. 30, 2011 - MarketWatch
Court upholds stem-cell research funding: reports 10:46 a.m. July 27, 2011 - Val Brickates Kennedy
Trade-Ideas: Geron (GERN) Is Today's Strong On High Relative Volume Stock 39 min ago - TheStreet.com
Geron Corporation (GERN): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Jan. 12, 2015 - Zacks.com
Seeking Alpha's Biotech Weekly: A Merck Purchase, Spectacular Auspex, And More 4:00 p.m. Dec. 19, 2014 - Seeking Alpha
Geron Enters 2015 On A More Assured Note 3:28 p.m. Dec. 18, 2014 - Seeking Alpha
Market Has Not Yet Noticed Potential in Geron (GERN); Have You? - Tale of the Tape 9:02 a.m. Dec. 17, 2014 - Zacks.com
4 Top Ranked Biotech Stocks that Beat the Market in 2014 - Analyst Blog 11:26 a.m. Dec. 16, 2014 - Zacks.com
Today's Dead Cat Bounce Stock: Geron (GERN) 9:51 a.m. Dec. 11, 2014 - TheStreet.com
Why Geron Corporation (GERN) Stock Might be a Great Pick - Tale of the Tape 8:57 a.m. Dec. 10, 2014 - Zacks.com
Geron (GERN) Stock: Moving Average Crossover Alert - Tale of the Tape 9:47 a.m. Dec. 5, 2014 - Zacks.com
BioTime Harnesses Geron's Stem Cell Technology And Its Founder; Is That Enough To Survive The Biotech Revolution? 10:51 a.m. Dec. 3, 2014 - Seeking Alpha
Geron (GERN) Showing Signs Of A Dead Cat Bounce Today 10:10 a.m. Nov. 26, 2014 - TheStreet.com
Strong On High Relative Volume: Geron (GERN) 10:01 a.m. Nov. 21, 2014 - TheStreet.com
Biotech Stock Roundup: Geron Soars on $935M J&J Deal, Gilead's Harvoni Approved in the EU - Analyst Blog 11:23 a.m. Nov. 19, 2014 - Zacks.com
Can the Rally in Geron (GERN) Shares Continue? - Tale of the Tape 8:43 a.m. Nov. 19, 2014 - Zacks.com
Incyte Building Blockbuster Drug One Disease At A Time 2:58 p.m. Nov. 17, 2014 - Investors Business Daily
Geron (GERN) Stock Surges Following Johnson & Johnson Licensing Deal 10:40 a.m. Nov. 17, 2014 - TheStreet.com
Strength Seen in Geron (GERN): Stock Surges 19.5% - Tale of the Tape 9:25 a.m. Nov. 17, 2014 - Zacks.com
Geron Collaborates with J&J for Imetelstat - Analyst Blog 6:00 p.m. Nov. 14, 2014 - Zacks.com
Geron's Short Squeeze Is Here 3:40 p.m. Nov. 14, 2014 - Seeking Alpha
Stock Market Today: Stocks Mixed as Retail Sales Climb, House OKs Keystone Pipeline 3:36 p.m. Nov. 14, 2014 - TheStreet.com
Biotech Stocks Technical Insight -- ARIAD Pharma, Geron, PDL BioPharma, Cytori Therapeutics, and Navidea Biopharma 9:15 a.m. Dec. 18, 2014 - PR Newswire - PRF
Geron Announces Early HSR Clearance for Global Strategic Collaboration with Janssen 7:16 a.m. Dec. 16, 2014 - Thomson Reuters ONE
Geron to Host Analyst and Investor Meeting on December 8 9:31 p.m. Dec. 5, 2014 - Thomson Reuters ONE
Geron Announces Publication of Preclinical Data on Imetelstat Activity in Acute Myelogenous Leukemia 4:16 p.m. Dec. 4, 2014 - Thomson Reuters ONE
Geron to Present at the 26th Annual Piper Jaffray Healthcare Conference 4:16 p.m. Nov. 26, 2014 - Thomson Reuters ONE
Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 9:00 a.m. Nov. 18, 2014 - PR Newswire - PRF
Geron to Present at the Stifel Healthcare Conference 4:16 p.m. Nov. 14, 2014 - Thomson Reuters ONE
Geron Announces Global Strategic Collaboration with Janssen to Develop and Commercialize Imetelstat 4:16 p.m. Nov. 13, 2014 - Thomson Reuters ONE
Geron Announces Presentations at American Society of Hematology Annual Meeting 9:15 a.m. Nov. 6, 2014 - Thomson Reuters ONE
Geron Announces Removal of Full Clinical Hold on Imetelstat IND 7:31 a.m. Nov. 3, 2014 - Thomson Reuters ONE
Biotech Equities Technical Analysis - ARIAD Pharma, Novavax, Galena Biopharma, Geron, and Celldex Therapeutics 7:40 a.m. Oct. 15, 2014 - PR Newswire - PRF
GERON SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors In Geron Corporation's January 2014 Offering To Contact The Firm 3:00 p.m. Oct. 10, 2014 - PR Newswire - PRF
Biotech Equities Technical Review -- Celldex Therapeutics, Synthetic Biologics, Geron, Catalyst Pharmaceutical Partners, and NPS Pharmaceuticals 8:15 a.m. Sept. 8, 2014 - PR Newswire - PRF
Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 6:00 a.m. Aug. 21, 2014 - PR Newswire - PRF
Geron Corporation Reports Second Quarter 2014 Financial Results 3:06 p.m. Aug. 11, 2014 - Thomson Reuters ONE
Geron to Assume Sponsorship of Myelofibrosis IST and IND 6:30 a.m. Aug. 5, 2014 - Thomson Reuters ONE
Biotech Stocks Technical Data -- MannKind, ARIAD Pharma, Galena Biopharma, Geron, and Peregrine Pharma 8:00 a.m. Aug. 1, 2014 - PR Newswire - PRF
Geron Announces Conference Call to Discuss Second Quarter 2014 Financial Results 6:31 a.m. July 30, 2014 - Thomson Reuters ONE
Stock Watchout on Biotech Industry -- Research on ARIAD Pharma, Geron, Seattle Genetics, and Sarepta Therapeutics 6:30 a.m. June 26, 2014 - PR Newswire - PRF
Sales, Clinical Hold Removal, Trial Initiations, and Committee Recommendations - Analyst Notes on Geron, Zalicus, Northwest Biotherapeutics, Progenics and TG Therapeutics 4:30 a.m. June 17, 2014 - PR Newswire - PRF
Baker Hughes, Halliburton gain on potential merger; Fossil in red 10:07 a.m. Nov. 14, 2014 - Sue Chang
Looming $40 crude and how to vape your way to profits 5:47 a.m. Nov. 14, 2014 - Shawn Langlois
Baker Hughes shares rise on possible buyout 6:02 p.m. Nov. 13, 2014 - Wallace Witkowski
Herbalife shares drop after hours as earnings disappoint 6:58 p.m. Nov. 3, 2014 - Wallace Witkowski
Geron's stock soars after FDA lifts hold on new drug application 7:48 a.m. Nov. 3, 2014 - Tomi Kilgore
Geron's stock jumps 35% premarket after FDA lifts hold on new drug application 7:35 a.m. Nov. 3, 2014 - Tomi Kilgore
FDA places hold on Geren's Imetelstat application 7:25 a.m. March 12, 2014 - MarketWatch.com
Charting the latest market whipsaw 10:59 a.m. Nov. 11, 2013 - Michael Ashbaugh
Oracle active, Geron shares fall after hours 6:06 p.m. Dec. 3, 2012 - Carla Mozee
Geron to discontinue brain-cancer drug development 4:38 p.m. Dec. 3, 2012 - MarketWatch.com
BioTime offers equity stake for Geron assets 8:47 a.m. Oct. 18, 2012 - MarketWatch.com
Monday’s biggest gaining and declining stocks 1:42 p.m. Sept. 10, 2012 - MarketWatch
Geron ends breast cancer study of Imetelstat 7:06 a.m. Sept. 10, 2012 - MarketWatch.com
Stocks to Watch Friday: Splunk, Zumiez, Pandora 3:59 p.m. Aug. 30, 2012 - David B. Wilkerson
Thursday’s biggest gaining and declining stocks 3:31 p.m. Aug. 30, 2012 - MarketWatch
Geron climbs 11% on analyst rating 9:56 a.m. Aug. 30, 2012 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 5:37 p.m. Nov. 15, 2011 - Kate Gibson
Financial uncertainty nixed Geron stem cell work 2:09 p.m. Nov. 15, 2011 - MarketWatch.com
Stocks to watch Friday: Global Crossing, Clarcor 5:42 a.m. Sept. 30, 2011 - MarketWatch
Court upholds stem-cell research funding: reports 10:46 a.m. July 27, 2011 - Val Brickates Kennedy
Trade-Ideas: Geron (GERN) Is Today's Strong On High Relative Volume Stock 39 min ago - TheStreet.com
Geron Corporation (GERN): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Jan. 12, 2015 - Zacks.com
Seeking Alpha's Biotech Weekly: A Merck Purchase, Spectacular Auspex, And More 4:00 p.m. Dec. 19, 2014 - Seeking Alpha
Geron Enters 2015 On A More Assured Note 3:28 p.m. Dec. 18, 2014 - Seeking Alpha
Market Has Not Yet Noticed Potential in Geron (GERN); Have You? - Tale of the Tape 9:02 a.m. Dec. 17, 2014 - Zacks.com
4 Top Ranked Biotech Stocks that Beat the Market in 2014 - Analyst Blog 11:26 a.m. Dec. 16, 2014 - Zacks.com
Today's Dead Cat Bounce Stock: Geron (GERN) 9:51 a.m. Dec. 11, 2014 - TheStreet.com
Why Geron Corporation (GERN) Stock Might be a Great Pick - Tale of the Tape 8:57 a.m. Dec. 10, 2014 - Zacks.com
Geron (GERN) Stock: Moving Average Crossover Alert - Tale of the Tape 9:47 a.m. Dec. 5, 2014 - Zacks.com
BioTime Harnesses Geron's Stem Cell Technology And Its Founder; Is That Enough To Survive The Biotech Revolution? 10:51 a.m. Dec. 3, 2014 - Seeking Alpha
Geron (GERN) Showing Signs Of A Dead Cat Bounce Today 10:10 a.m. Nov. 26, 2014 - TheStreet.com
Strong On High Relative Volume: Geron (GERN) 10:01 a.m. Nov. 21, 2014 - TheStreet.com
Biotech Stock Roundup: Geron Soars on $935M J&J Deal, Gilead's Harvoni Approved in the EU - Analyst Blog 11:23 a.m. Nov. 19, 2014 - Zacks.com
Can the Rally in Geron (GERN) Shares Continue? - Tale of the Tape 8:43 a.m. Nov. 19, 2014 - Zacks.com
Incyte Building Blockbuster Drug One Disease At A Time 2:58 p.m. Nov. 17, 2014 - Investors Business Daily
Geron (GERN) Stock Surges Following Johnson & Johnson Licensing Deal 10:40 a.m. Nov. 17, 2014 - TheStreet.com
Strength Seen in Geron (GERN): Stock Surges 19.5% - Tale of the Tape 9:25 a.m. Nov. 17, 2014 - Zacks.com
Geron Collaborates with J&J for Imetelstat - Analyst Blog 6:00 p.m. Nov. 14, 2014 - Zacks.com
Geron's Short Squeeze Is Here 3:40 p.m. Nov. 14, 2014 - Seeking Alpha
Stock Market Today: Stocks Mixed as Retail Sales Climb, House OKs Keystone Pipeline 3:36 p.m. Nov. 14, 2014 - TheStreet.com
Biotech Stocks Technical Insight -- ARIAD Pharma, Geron, PDL BioPharma, Cytori Therapeutics, and Navidea Biopharma 9:15 a.m. Dec. 18, 2014 - PR Newswire - PRF
Geron Announces Early HSR Clearance for Global Strategic Collaboration with Janssen 7:16 a.m. Dec. 16, 2014 - Thomson Reuters ONE
Geron to Host Analyst and Investor Meeting on December 8 9:31 p.m. Dec. 5, 2014 - Thomson Reuters ONE
Geron Announces Publication of Preclinical Data on Imetelstat Activity in Acute Myelogenous Leukemia 4:16 p.m. Dec. 4, 2014 - Thomson Reuters ONE
Geron to Present at the 26th Annual Piper Jaffray Healthcare Conference 4:16 p.m. Nov. 26, 2014 - Thomson Reuters ONE
Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 9:00 a.m. Nov. 18, 2014 - PR Newswire - PRF
Geron to Present at the Stifel Healthcare Conference 4:16 p.m. Nov. 14, 2014 - Thomson Reuters ONE
Geron Announces Global Strategic Collaboration with Janssen to Develop and Commercialize Imetelstat 4:16 p.m. Nov. 13, 2014 - Thomson Reuters ONE
Geron Announces Presentations at American Society of Hematology Annual Meeting 9:15 a.m. Nov. 6, 2014 - Thomson Reuters ONE
Geron Announces Removal of Full Clinical Hold on Imetelstat IND 7:31 a.m. Nov. 3, 2014 - Thomson Reuters ONE
Biotech Equities Technical Analysis - ARIAD Pharma, Novavax, Galena Biopharma, Geron, and Celldex Therapeutics 7:40 a.m. Oct. 15, 2014 - PR Newswire - PRF
GERON SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors In Geron Corporation's January 2014 Offering To Contact The Firm 3:00 p.m. Oct. 10, 2014 - PR Newswire - PRF
Biotech Equities Technical Review -- Celldex Therapeutics, Synthetic Biologics, Geron, Catalyst Pharmaceutical Partners, and NPS Pharmaceuticals 8:15 a.m. Sept. 8, 2014 - PR Newswire - PRF
Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 6:00 a.m. Aug. 21, 2014 - PR Newswire - PRF
Geron Corporation Reports Second Quarter 2014 Financial Results 3:06 p.m. Aug. 11, 2014 - Thomson Reuters ONE
Geron to Assume Sponsorship of Myelofibrosis IST and IND 6:30 a.m. Aug. 5, 2014 - Thomson Reuters ONE
Biotech Stocks Technical Data -- MannKind, ARIAD Pharma, Galena Biopharma, Geron, and Peregrine Pharma 8:00 a.m. Aug. 1, 2014 - PR Newswire - PRF
Geron Announces Conference Call to Discuss Second Quarter 2014 Financial Results 6:31 a.m. July 30, 2014 - Thomson Reuters ONE
Stock Watchout on Biotech Industry -- Research on ARIAD Pharma, Geron, Seattle Genetics, and Sarepta Therapeutics 6:30 a.m. June 26, 2014 - PR Newswire - PRF
Sales, Clinical Hold Removal, Trial Initiations, and Committee Recommendations - Analyst Notes on Geron, Zalicus, Northwest Biotherapeutics, Progenics and TG Therapeutics 4:30 a.m. June 17, 2014 - PR Newswire - PRF
(0)
(0)